On April 9, 2025 CiMaas reported a new grant from LIOF to further explore the recently developed and patented feeder cell technology (Press release, CiMaas, APR 9, 2025, View Source [SID1234651850]). A GMP grade feeder cells master bank has been previously generated and serves as starting material.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Previously we have seen identical expansion rates and cytotoxicity of the expanded NK cells, and within this grant we will more extensively validate the NK cell expansion, activation and functional characteristics in comparison to the original protocol in which irradiation technology was used.

Finally with in the grant we will validate all characteristics in large-scale NK cell batches with numbers ready for clinical applications in cancer.